dabigatran has been researched along with albuterol in 1 studies
| Studies (dabigatran) | Trials (dabigatran) | Recent Studies (post-2010) (dabigatran) | Studies (albuterol) | Trials (albuterol) | Recent Studies (post-2010) (albuterol) |
|---|---|---|---|---|---|
| 3,887 | 261 | 3,490 | 10,108 | 3,059 | 2,058 |
| Protein | Taxonomy | dabigatran (IC50) | albuterol (IC50) |
|---|---|---|---|
| Beta-2 adrenergic receptor | Homo sapiens (human) | 1.2618 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodsky, SV; Ivanov, I; Medipally, AK; Qaisar, S; Rovin, BH; Satoskar, AA; Xiao, M | 1 |
1 other study(ies) available for dabigatran and albuterol
| Article | Year |
|---|---|
Role of glomerular filtration rate-modifying drugs in the development of anticoagulant-related nephropathy.
Topics: Acute Kidney Injury; Albuterol; Animals; Antihypertensive Agents; Antithrombins; Bronchodilator Agents; Dabigatran; Disease Models, Animal; Enalapril; Glomerular Filtration Rate; Male; Nephrectomy; Rats; Rats, Sprague-Dawley | 2021 |